Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > News > Obducat's CEO comments on the annual accounts for 2005

February 17th, 2006

Obducat's CEO comments on the annual accounts for 2005

Abstract:
Obducat’s industrial order for a NIL (nano-imprint lithography) machine after the end of the reporting period shows that a very important milestone has been reached: NIL technology can be used in mass production. The customer manufactures optical components that are part of a consumer electronics product from Samsung which will be launched on the market in May. It is also interesting that the customer who placed the order now for a further NIL machine had originally expected to place a second order first in autumn 2006. This breakthrough is the result of a very hard and committed effort on the part of Obducat’s personnel over a long period.

Source:
Obducat

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Nanoelectronics

Key element for a scalable quantum computer: Physicists from Forschungszentrum Jülich and RWTH Aachen University demonstrate electron transport on a quantum chip September 23rd, 2022

Reduced power consumption in semiconductor devices September 23rd, 2022

Atomic level deposition to extend Moore’s law and beyond July 15th, 2022

Controlled synthesis of crystal flakes paves path for advanced future electronics June 17th, 2022

Announcements

Heat-resistant nanophotonic material could help turn heat into electricity: The key to beating the heat is degrading the materials in advance September 23rd, 2022

Chicago Quantum Exchange welcomes six new partners highlighting quantum technology solutions, from Chicago and beyond September 23rd, 2022

“Twisty” photons could turbocharge next-gen quantum communication: Team’s on-chip technology uses orbital angular momentum to encode more information into a single photon September 23rd, 2022

Wrapping of nanosize copper cubes can help convert carbon dioxide into other chemicals September 23rd, 2022

Tools

An alternative to MINFLUX that enables nanometre resolution in a confocal microscope August 26th, 2022

Atomic level deposition to extend Moore’s law and beyond July 15th, 2022

Nano-rust: Smart additive for autonomous temperature control: FAU researchers develop a new, versatile method for temperature monitoring in materials July 8th, 2022

New technology helps reveal inner workings of human genome June 24th, 2022

Patents/IP/Tech Transfer/Licensing

Study finds nanomedicine targeting lymph nodes key to triple negative breast cancer treatment: In mice, nanomedicine can remodel the immune microenvironment in lymph node and tumor tissue for long-term remission and lung tumor elimination in this form of metastasized breast cance May 13th, 2022

Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021

Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020

HORIBA Medical and CEA-Leti Strengthen Their Partnership to Develop Tomorrow’s Diagnostics at the Point of Care July 21st, 2020

Financial Reports

180 Degree Capital Corp. Reports +14.2% Growth in Q1 2021, $10.60 Net Asset Value Per Share as of March 31, 2021, and Developments From Q2 2021 May 11th, 2021

Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021

Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021

180 Degree Capital Corp. Reports +6.7% Growth in Q4 2020, $9.28 Net Asset Value per Share as of December 31, 2020, and Developments from Q1 2021 Including Expected Investment in a Planned SPAC Sponsor February 22nd, 2021

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project